Our Mission
At PragmaClin®, we are dedicated to revolutionizing neurological healthcare through innovative digital solutions. Our mission is to enhance the quality of life for individuals with neurological conditions by providing accurate, accessible, and comprehensive digital assessment tools. We strive to lead the MedTech industry with cutting-edge technology, driving impactful change in healthcare delivery and ensuring equal access to advanced tools for all. With a commitment to excellence and a passion for progress, PragmaClin® is transforming the future of neurological care.
What Makes Us Different?
Remote Accesibility
Allows for remote assessments, making it convenient for people with Parkinson's who cannot easily visit healthcare facilities
No Wearables
No wearables allow for ease of use, less hardware maintenance and improved comfort for users
Proactive Care
Facilitates proactive care management by identifying potential issues before they become critical.
Our Growth
November 2020
PragmaClin® Becomes Incorporated
Q1/Q2 2022
First prototype developed and first pitch competition won
Q3 2023
Fully operational prototype ready for external testing
Q1 2024
Secured Lead Investor for Pre-Seed Round; $1M project approved by Provincial and Federal agencies.
First project funded by Provincial and Federal agencies
Q2 2021
Second project funded by Provincial and Federal Agencies
Q4 2022
Completed Data Collection Trial with Kings College Dubai
Q4 2023
Project Funding by Provincial and Federal Agencies
Q2 2024
Market Opportunity
The PRIMS® system addresses a crucial market need in neurological care, especially for Parkinson’s Disease. With an aging population, neurological disorders are on the rise, increasing the demand for efficient and accurate assessments. Traditional methods are often time-consuming and subjective. PRIMS® offers a digital solution for comprehensive, real-time assessments, enhancing outcomes and healthcare efficiency. By reducing the need for frequent in-person visits and providing actionable insights, PRIMS® meets the urgent demand for scalable, cost-effective neurological assessments.